De novo fragment-based design of inhibitors of DXS guided by spin-diffusion-based NMR spectroscopy

Abstract

A ligand-based NMR methodology (STI) enabled <italic>de novo</italic> fragment-based design of inhibitors of the enzyme DXS present in the non-mevalonate pathway in the absence of X-ray co-crystal structures.